100 related articles for article (PubMed ID: 25591760)
21. E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia.
Liu Y; Chen P; Chen G; Chen X
Ann Hematol; 2023 Dec; 102(12):3345-3355. PubMed ID: 37665348
[TBL] [Abstract][Full Text] [Related]
22. SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study.
Wan H; Zhu J; Chen F; Xiao F; Huang H; Han X; Zhong L; Zhong H; Xu L; Ni B; Zhong J
J Exp Clin Cancer Res; 2014 Nov; 33(1):90. PubMed ID: 25398670
[TBL] [Abstract][Full Text] [Related]
23. Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.
Liu Y; Lei H; Zhang J; Wang J; Li K; Dong W
PLoS One; 2015; 10(8):e0135318. PubMed ID: 26267616
[TBL] [Abstract][Full Text] [Related]
24. NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia.
Cheong HS; Koh Y; Ahn KS; Lee C; Shin HD; Yoon SS
Pharmacogenet Genomics; 2014 Sep; 24(9):436-41. PubMed ID: 25000516
[TBL] [Abstract][Full Text] [Related]
25. Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.
Hou X; Hu Z; Huang X; Chen Y; He X; Xu H; Wang N
J Mol Med (Berl); 2014 May; 92(5):487-95. PubMed ID: 24370940
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
Gamazon ER; Lamba JK; Pounds S; Stark AL; Wheeler HE; Cao X; Im HK; Mitra AK; Rubnitz JE; Ribeiro RC; Raimondi S; Campana D; Crews KR; Wong SS; Welsh M; Hulur I; Gorsic L; Hartford CM; Zhang W; Cox NJ; Dolan ME
Blood; 2013 May; 121(21):4366-76. PubMed ID: 23538338
[TBL] [Abstract][Full Text] [Related]
27. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
28. Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients.
Kim KI; Huh IS; Kim IW; Park T; Ahn KS; Yoon SS; Yoon JH; Oh JM
Eur J Cancer; 2013 Jan; 49(2):403-10. PubMed ID: 22964418
[TBL] [Abstract][Full Text] [Related]
29. OPN gene polymorphisms are associated with susceptibility and clinicopatholigical characteristics of cervical cancer in a Chinese cohort.
Xu Q; Yuan B; Xue F; Zhang L; Li J; Guo H; Yue T
Cancer Biomark; 2011; 10(5):233-9. PubMed ID: 22699784
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin, Bone Morphogenetic Protein-4, and Vitamin D Receptor Gene Polymorphisms in the Susceptibility and Clinical Severity of Spinal Tuberculosis.
Wang G; Xie L; Hu J; Lu H; Liu X; Cao Y; Liu B; Zhang Y; Shen X
Cell Physiol Biochem; 2017; 41(5):1881-1893. PubMed ID: 28376475
[TBL] [Abstract][Full Text] [Related]
31. SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
Kim JH; Lee C; Cheong HS; Koh Y; Ahn KS; Kim HL; Shin HD; Yoon SS
Cancer Chemother Pharmacol; 2016 Sep; 78(3):533-40. PubMed ID: 27422302
[TBL] [Abstract][Full Text] [Related]
32. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the Osteopontin Are Associated with Susceptibility to Ankylosing Spondylitis in a Han Chinese Population.
Li J; Cai Y; Wang Z; Deng A; Yang G
Biomed Res Int; 2018; 2018():3458439. PubMed ID: 29581970
[TBL] [Abstract][Full Text] [Related]
34. Optimal dose and schedule of consolidation in AML: is there a standard?
Schiffer CA
Best Pract Res Clin Haematol; 2014; 27(3-4):259-64. PubMed ID: 25455275
[TBL] [Abstract][Full Text] [Related]
35. The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia.
Zhong Y; Chen B; Feng J; Cheng L; Li Y; Qian J; Ding J; Gao F; Xia G; Chen N; Lu Z
Leuk Lymphoma; 2010 Jun; 51(6):1115-20. PubMed ID: 20536350
[TBL] [Abstract][Full Text] [Related]
36. Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Martínez-Cuadrón D; Poveda JL; Sanz MÁ; Aliño SF
Pharmacogenet Genomics; 2017 Jul; 27(7):270-274. PubMed ID: 28570300
[TBL] [Abstract][Full Text] [Related]
37. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.
Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Martínez-Cuadrón D; Rojas L; Rodríguez-Veiga R; Boluda B; Sendra L; Cervera J; Poveda JL; Sanz MÁ; Aliño SF
Leuk Lymphoma; 2017 Dec; 58(12):2880-2894. PubMed ID: 28573946
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
Xie XT; Jiang SY; Li BS; Yang LL
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.
Xu AP; Bai J; Lü J; Liang YY; Li JG; Lai DY; Wan X; Huang HH
Chin Med J (Engl); 2007 Dec; 120(23):2124-8. PubMed ID: 18167187
[TBL] [Abstract][Full Text] [Related]
40. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.
Fanciullino R; Farnault L; Donnette M; Imbs DC; Roche C; Venton G; Berda-Haddad Y; Ivanov V; Ciccolini J; Ouafik L; Lacarelle B; Costello R
Blood Adv; 2018 Mar; 2(5):462-469. PubMed ID: 29490977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
